Regulatory response to contaminated valsartan

BMJ. 2018 Sep 12:362:k3855. doi: 10.1136/bmj.k3855.

Authors

Rita Banzi¹, Vittorio Bertele'²

Affiliations

¹ Center for Drug Regulatory Policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via La Masa 19, 20156 Milan, Italy rita.banzi@marionegri.it.
² Center for Drug Regulatory Policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via La Masa 19, 20156 Milan, Italy.

PMID: 30209051
DOI: 10.1136/bmj.k3855

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cohort Studies
Dimethylnitrosamine*
Humans
Neoplasms*
Tetrazoles
Valsartan

Substances

Tetrazoles
Valsartan
Dimethylnitrosamine